Feed UPC
UP

Universe Pharmaceuticals INC

UPC · NASDAQ

$4.85 -0.21% (-$0.01)
1M -13.43%
Market Cap $3.06M
P/E Ratio -
Div. Yield -
ROE 6.91%

Bulios Fair Price

$6.06

24.9% upside

Current Price

$4.85

Undervalued Fair Value Overvalued

According to Bulios Fair Price, UPC is currently undervalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Weak
2/9
Valuation
100 /100
Cheap
P/B 0.05x
P/S 0.17x
EV/EBITDA N/A
Growth
13 /100
Declining
Book val. growth 6.52%
Rev. growth 23.66%
FCF growth N/A
Profitability
14 /100
Weak
Net margin 20.56%
Op. margin 16.33%
FCF margin 30.23%
Quality
3 /100
Poor
ROE 6.91%
ROA 5.30%
Asset turnover 0.26x
Debt
69 /100
Low
Current ratio 4.07x
Int. coverage -14.83x
Debt/Equity 0.16x
Stability
53 /100
Moderate
Rev. volatility 4.71%
EPS volatility 38.13%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about UPC
Online

About the company

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Gang Lai

Employees

216

Headquarters

Ji'An

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.